You are here:

Omega-3-acid ethyl esters (Omacor®)


Not recommended for use within the NHS in Scotland.


This is based on the lack of long-term data to indicate that reductions in triglyceride levels provide real benefit in terms of reducing cardiovascular events, on a lack of evidence of increased patient acceptability of the product, and lack of a pharmacoeconomic case for the drug.

Drug Details

Drug Name: Omega-3-acid ethyl esters (Omacor®)
SMC Drug ID: 16/02
Manufacturer: Solvay Healthcare Ltd
Indication: Hypertriglyceridaemia
BNF Category:
Sub Category: 2.13 Local sclerosants
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 8 November 2002